Abbott Snags U.S. Clearance To Enter The Obesity Arena, Rivaling DexcomInvestors Business Daily • 06/10/24
Abbott Receives U.S. FDA Clearance for Two New Over-the-Counter Continuous Glucose Monitoring SystemsPRNewsWire • 06/10/24
Abbott (ABT) Is Considered a Good Investment by Brokers: Is That True?Zacks Investment Research • 06/06/24
Cadrenal Therapeutics Highlights Presentation of New Trial Data at ISHLT Conference Demonstrating the Importance of Anticoagulation Quality in LVAD PatientsPRNewsWire • 06/03/24
Wall Street Favorites: 3 Healthcare Stocks With Strong Buy Ratings for May 2024InvestorPlace • 05/28/24
Wall Street Analysts See Abbott (ABT) as a Buy: Should You Invest?Zacks Investment Research • 05/21/24
Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on ItZacks Investment Research • 05/15/24